Product Information
ESLICARBAZEPINE 800 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.6479 per EA under NDC 68180029306. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
800 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180029306
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESLICARBAZEPINE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA211246On Market Since
5/6/2025
Pharmacological Classes
Price Statistics
The NADAC for ESLICARBAZEPINE 800 MG TABLET has been published 45 times since Aug 20, 2025, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6479 per EA |
|---|---|
| All-time high | $4.0499 (Dec 10, 2025) |
| All-time low | $2.6479 (Jun 17, 2026) |
| 52-week high | $4.0499 |
| 52-week low | $2.6479 |
| Median price | $3.1944 |
| Average price | $3.4220 |
| Largest weekly change | -16.0% (Jan 21, 2026) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESLICARBAZEPINE 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESLICARBAZEPINE 800 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $2.6479 per EA (NDC 68180029306), effective Jun 24, 2026.
How has the price of ESLICARBAZEPINE 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESLICARBAZEPINE 800 MG TABLET has declined 26.8%. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for ESLICARBAZEPINE 800 MG TABLET?
Since Aug 20, 2025, the NADAC for ESLICARBAZEPINE 800 MG TABLET has ranged from a low of $2.6479 (Jun 17, 2026) to a high of $4.0499 (Dec 10, 2025), with a median of $3.1944 per EA.
Are there cheaper alternatives to ESLICARBAZEPINE 800 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ESLICARBAZEPINE 800 MG TABLET, but none are currently priced below it.
Who manufactures ESLICARBAZEPINE 800 MG TABLET?
ESLICARBAZEPINE 800 MG TABLET (NDC 68180029306) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification